COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 83 filers reported holding COGENT BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,330,887 | -26.0% | 513,747 | -41.0% | 0.00% | 0.0% |
| Q1 2024 | $5,854,444 | +122.9% | 871,197 | +95.0% | 0.00% | – |
| Q4 2023 | $2,627,019 | -32.6% | 446,772 | +11.7% | 0.00% | -100.0% |
| Q3 2023 | $3,898,849 | -9.7% | 399,882 | +9.6% | 0.00% | 0.0% |
| Q2 2023 | $4,319,634 | -27.7% | 364,834 | -34.1% | 0.00% | 0.0% |
| Q1 2023 | $5,974,747 | -20.0% | 553,730 | -14.2% | 0.00% | -50.0% |
| Q4 2022 | $7,464,719 | +67325.9% | 645,737 | -13.0% | 0.00% | -33.3% |
| Q3 2022 | $11,071 | +231.8% | 741,988 | +100.6% | 0.00% | +200.0% |
| Q2 2022 | $3,337 | -99.8% | 369,925 | +106.6% | 0.00% | – |
| Q1 2022 | $1,341,000 | +97.5% | 179,033 | +126.2% | 0.00% | – |
| Q4 2021 | $679,000 | -46.1% | 79,159 | -47.1% | 0.00% | – |
| Q3 2021 | $1,259,000 | +269.2% | 149,693 | +285.0% | 0.00% | – |
| Q1 2021 | $341,000 | +194.0% | 38,882 | +277.0% | 0.00% | – |
| Q4 2020 | $116,000 | – | 10,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,884,977 | $52,708,902 | 10.29% |
| COMMODORE CAPITAL LP | 4,772,421 | $51,494,423 | 7.84% |
| TCG Crossover Management, LLC | 3,631,042 | $39,178,943 | 7.64% |
| Fairmount Funds Management LLC | 2,758,975 | $29,769,340 | 5.12% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,411,509 | 4.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 579,264 | $6,250,259 | 2.58% |
| 5AM Venture Management, LLC | 790,440 | $8,528,848 | 2.18% |
| Ghost Tree Capital, LLC | 550,000 | $5,935,000 | 1.75% |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23,297,272 | 1.69% |
| HighVista Strategies LLC | 183,984 | $1,985,187 | 1.62% |